Centene Corporation
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 125.98B | 144.55B | 154.00B | 163.07B | 194.78B | 19.4% | |
| Cost of Revenue | (111.78B) | (127.89B) | (136.68B) | (146.24B) | (170.94B) | 16.9% | |
Gross Profit | 14.20B | 16.66B | 17.32B | 16.83B | 23.83B | 41.6% | |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | |
| Selling, General & Administrative | (9.60B) | (11.59B) | (12.56B) | (12.40B) | (13.26B) | 7.0% | |
| General & Administrative | (10.17B) | — | — | — | (13.26B) | — | |
| Depreciation & Amortization | (1.33B) | (1.43B) | (1.29B) | (1.24B) | (1.27B) | 2.7% | |
Operating Income (EBIT) | 1.78B | 1.32B | 2.93B | 3.17B | -7.62B | -339.9% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | — | — | |
| Interest Expense | (665.00M) | (665.00M) | (725.00M) | (702.00M) | (678.00M) | -3.4% | |
| Other Income/Expenses (Net) | 29.00M | 644.00M | 668.00M | 1.08B | 890.41M | -17.7% | |
Income Before Tax | 1.81B | 1.96B | 3.60B | 4.26B | -6.73B | -258.0% | |
| Income Tax Expense | (477.00M) | (760.00M) | (899.00M) | (963.00M) | (50.96M) | -105.3% | |
Net Income | 1.35B | 1.20B | 2.70B | 3.31B | -6.67B | -301.9% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $2 | $2 | $5 | $6 | $-14 | -315.0% | |
| Weighted Avg Shares Outstanding | 582.83M | 575.19M | 543.32M | 521.79M | 491.07M | -5.9% | |
| Weighted Avg Shares Outstanding (Diluted) | 590.52M | 582.04M | 545.70M | 523.74M | 491.07M | -6.2% | |
EBITDA | 3.81B | 4.06B | 5.62B | 6.20B | -5.14B | -182.9% |
Explore CNC
CNC in the Healthcare
Large Cap